Liposome: classification, preparation, and applications
By A. Akbarzadeh, Rogaie Rezaei-Sadabady, S. Davaran, S. Joo, N. Zarghami, Y. Hanifehpour, M. Samiei, M. Kouhi, Kazem Nejati-Koshki. Nanoscale Research Letters, 2013
2,766 citations recorded by the source corpus.
Liposomes, sphere-shaped vesicles consisting of one or more phospholipid bilayers, were first described in the mid-60s. Today, they are a very useful reproduction, reagent, and tool in various scientific disciplines, including mathematics and theoretical physics, biophysics, chemistry, colloid science, biochemistry, and biology. Since then, liposomes have made their way to the market. Among several talented new drug delivery systems, liposomes characterize an advanced technology to deliver active molecules to the site of action, and at present, several formulations are in clinical use. Research on liposome technology has progressed from conventional vesicles to ‘second-generation liposomes’, in which long-circulating liposomes are obtained by modulating the lipid composition, size, and charge of the vesicle. Liposomes with modified surfaces have also been developed using several molecules, such as glycolipids or sialic acid. This paper summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations in respect to industrial applicability and regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.
Subfields: Biomaterials, Molecular Biology, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/46e80bca68ae6db71c3ebfa5b509357ea3662a5a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Pharmaceutical Science
Citations in the corpus
- Carbon nanotubes: properties, synthesis, purification, and medical applications (2014, background): “There remains amount of essential issues that require to be resolved, on the other hand, such as homogeneity of the material that contains wide distribution of the nanotube's diameters, unlike nanostructures, presence of residual metals; division of the individual nanotubes; and a sensitivity to the”
- The Smart Drug Delivery System and Its Clinical Potential (2016, methodology): “Especially, when the diameter of liposome was decreased within the scope of 100 nm or less, liposomes have been widely used as advanced DDSs in numerous clinical trials such as anti-cancer, anti-inflammatory, anti-fungal drugs, and gene medicines [113, 114].”
- Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review (2018, background): “Uni-lamellar vesicles can be further divided into two groups, namely, large uni-lamellar vesicles (LUV) and small uni-lamellar vesicles (SUV) [33,34].”
- Dendrimers: synthesis, applications, and properties (2014, background): “Furthermore, highly sensitive analytical devices [77,78], MRI contrast agents [79], prion research [80], burn treatment [81], and EPR imaging with spin-labeled dendrimers [82-106] are some of the diverse areas of fascinating ongoing dendrimer research that are beyond the scope of this article.”